Liu Chang, Liu Liping, Wang Yinglu, Chen Xiaoli, Liu Jie, Peng Sheng, Pi Jingjiang, Zhang Qi, Tomlinson Brain, Chan Paul, Zhang Lin, Fan Huimin, Zheng Liang, Liu Zhongmin, Zhang Yuzhen
Key Laboratory of Arrhythmias of the Ministry of Education of China, Research Center for Translational Medicine, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China.
Department of Emergency Medicine, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China.
Front Cardiovasc Med. 2022 Feb 10;8:811670. doi: 10.3389/fcvm.2021.811670. eCollection 2021.
Hyperhomocysteinemia (HHcy) and abdominal obesity are risk factors for metabolic syndrome (MetS) and death from cardiovascular disease (CVD). Recent studies have shown a correlation between HHcy and abdominal obesity, suggesting that they may have a combined effect on the risk of MetS and CVD mortality. However, this suspicion remains to be confirmed, particularly in the elderly population. We explored their combined effects on the risk of MetS and CVD mortality among the community population aged 65 and above in China.
This prospective study enrolled 3,675 Chinese community residents aged 65 and above in May 2013 with 7-year follow-up of all-cause and CVD mortality. HHcy was defined as the blood homocysteine (Hcy) level >15 μmol/L and abdominal obesity as waist circumference (WC) ≥90 cm for men and ≥80 cm for women (HWC). All participants were grouped into four categories by WC and the blood level of Hcy: NWC (normal WC) /HHcy(-), NWC/HHcy(+), HWC/HHcy(-), and HWC/HHcy(+). The relationship of combined HHcy and abdominal obesity with MetS and metabolic profile was evaluated by logistic regression analysis and the association of combined HHcy and abdominal obesity with CVD and all-cause mortality evaluated by Cox regression analysis. The prevalence of HHcy, abdominal obesity and MetS in elderly Chinese community residents was 40.1, 59.3, and 41.4%, respectively. Using group without HHcy and abdominal obesity [NWC/HHcy(-)] as reference, the participants of other three groups had significantly higher risk of MetS and its component abnormalities, with HWC/HHcy(+) group having the highest risk (OR = 13.52; 95% CI = 8.61-14.55). After a median of 6.94 (±1.48) years follow-up, 454 deaths occurred with 135 CVD deaths. Compared with NWC/HHcy(-) group, the risk of 7-year follow-up CVD mortality (HR = 1.75; 95% CI = 1.02-3.03) and all-cause mortality (HR = 1.23; 95% CI = 1.04-2.18) of HWC/HHcy(+) group increased considerably after adjustment for major MetS and CVD risk factors.
There is high prevalence of HHcy, abdominal obesity, and MetS in the elderly Chinese community population. HHcy increases risk of MetS, CVD, and all-cause mortality, especially in the populations with abdominal obesity.
高同型半胱氨酸血症(HHcy)和腹型肥胖是代谢综合征(MetS)以及心血管疾病(CVD)死亡的危险因素。近期研究显示HHcy与腹型肥胖之间存在关联,提示它们可能对MetS风险和CVD死亡率具有联合作用。然而,这一推测仍有待证实,尤其是在老年人群中。我们探讨了它们对中国65岁及以上社区人群中MetS风险和CVD死亡率的联合作用。
这项前瞻性研究于2013年5月纳入了3675名65岁及以上的中国社区居民,并对全因死亡率和CVD死亡率进行了7年随访。HHcy定义为血液同型半胱氨酸(Hcy)水平>15μmol/L,腹型肥胖定义为男性腰围(WC)≥90cm、女性≥80cm(HWC)。所有参与者根据WC和Hcy血水平分为四类:正常WC(NWC)/HHcy(-)、NWC/HHcy(+)、HWC/HHcy(-)和HWC/HHcy(+)。通过逻辑回归分析评估HHcy与腹型肥胖联合对MetS和代谢谱的关系,通过Cox回归分析评估HHcy与腹型肥胖联合对CVD和全因死亡率的关联。中国老年社区居民中HHcy、腹型肥胖和MetS的患病率分别为40.1%、59.3%和41.4%。以无HHcy和腹型肥胖的组[NWC/HHcy(-)]为参照,其他三组参与者患MetS及其组分异常的风险显著更高,其中HWC/HHcy(+)组风险最高(OR = 13.52;95%CI = 8.61 - 14.55)。经过中位6.94(±1.48)年的随访,发生了454例死亡,其中135例为CVD死亡。与NWC/HHcy(-)组相比,在对主要MetS和CVD危险因素进行调整后,HWC/HHcy(+)组7年随访的CVD死亡率(HR = 1.75;95%CI = 1.02 - 3.03)和全因死亡率(HR = 1.23;95%CI = 1.04 - 2.18)大幅增加。
中国老年社区人群中HHcy、腹型肥胖和MetS的患病率较高。HHcy增加了MetS、CVD和全因死亡率的风险,尤其是在腹型肥胖人群中。